Article Information
History
- August 18, 2020.
Article Versions
- Version 1 (July 17, 2020 - 23:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Matthias Becker1,#,
- Monika Strengert2,3,#,
- Daniel Junker1,
- Tobias Kerrinnes4,
- Philipp D. Kaiser1,
- Bjoern Traenkle1,16,
- Heiko Dinter1,16,
- Julia Häring1,
- Anne Zeck1,
- Frank Weise1,
- Andreas Peter5,21,22,
- Sebastian Hörber5,21,22,
- Simon Fink1,
- Felix Ruoff1,
- Tamam Bakchoul9,
- Armin Baillot10,
- Stefan Lohse11,
- Markus Cornberg12,
- Thomas Illig13,
- Jens Gottlieb14,
- Sigrun Smola11,
- André Karch17,
- Klaus Berger17,
- Hans-Georg Rammensee6,7,8,
- Katja Schenke-Layland1,8,18,19,
- Annika Nelde6,8,20,
- Melanie Märklin8,20,
- Jonas S. Heitmann8,20,
- Juliane S. Walz6,8,15,20,
- Markus Templin1,
- Thomas O. Joos1,
- Ulrich Rothbauer1,16,#,
- Gérard Krause2,3 and
- Nicole Schneiderhan-Marra1,*
- 1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Germany
- 2Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
- 3TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
- 4Helmholtz-Institute for RNA-based Infection Research (HIRI), Würzburg, Germany
- 5Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany
- 6Institute for Cell Biology, Department of Immunology, University of Tuebingen, Tuebingen, Germany
- 7German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tuebingen, Tuebingen, Germany
- 8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
- 9Institute for Clinical and Experimental Transfusion Medicine, University Hospital Tuebingen, Tuebingen, Germany
- 10Niedersächsisches Landesgesundheitsamt, Department of Virology/Serology, Hannover, Germany
- 11Institute of Virology, Saarland University Medical Center, Homburg/Saar, Germany
- 12Department of Gastroenterology, Hepatology, Endocrinology, Hannover Medical School, Hannover, Germany; Centre for Individualized Infection Medicine (CiiM), Hannover, Germany
- 13Hannover Unified Biobank (HUB), Hannover Medical School, Hannover, Germany
- 14Clinic for Pneumonology, Hannover Medical School, Hannover, Germany
- 15Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
- 16Pharmaceutical Biotechnology, University of Tuebingen, Germany
- 17Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
- 18Department of Women’s Health, Research Institute for Womens’s Health, Eberhard-Karls-University, Tuebingen, Germany
- 19Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
- 20Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
- 21Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen, Tuebingen, Germany
- 22German Center for Diabetes Research (DZD), München-Neuherberg, Germany
- ↵* Corresponding author: Dr. Nicole Schneiderhan-Marra Markwiesenstrasse 55, 72770 Reutlingen, Germany Phone: 0049 7121 51530 815 Fax: 0049 7121 51530 16 E-Mail: Nicole.Schneiderhan{at}nmi.de
↵# These authors contributed equally to this work